Company overview
- Name in SEC record
- JOHNSON & JOHNSON
- SEC identifier (CIK)
- 0000200406
- Industry description (SEC SIC)
- Pharmaceutical Preparations
- Reported jurisdiction of incorporation
- New Jersey
- Stock tickers
- JNJ
- Reported exchanges
- NYSE
- Business address in SEC record
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Business phone in SEC record
- 732-524-2455
- Registration status / incorporation date
- Consult the relevant state registry
Reported financial fact
- Total assets · USD
- $201,061,000,000
- Balance-sheet date
- 2026-06-28
- Original filing
- 0000200406-26-000153
Assets are a reported balance-sheet measure, not revenue, profit, market value or a measure of investment safety. This value comes from the SEC’s CY2026Q2I assets frame; period ends vary between companies.
Recent SEC filings
| Form | Filed | Document | Source |
|---|---|---|---|
| 4 | 2026-09-10 | FORM 4 | View |
| 4 | 2026-09-10 | FORM 4 | View |
| 4 | 2026-09-10 | FORM 4 | View |
| 4 | 2026-09-04 | FORM 4 | View |
| 144 | 2026-09-02 | xsl144X01/primary_doc.xml | View |
| 3 | 2026-09-01 | FORM 3 | View |
| 4 | 2026-08-18 | FORM 4 | View |
| 144 | 2026-08-17 | xsl144X01/primary_doc.xml | View |
| 4 | 2026-08-14 | FORM 4 | View |
| 144 | 2026-08-13 | xsl144X01/primary_doc.xml | View |
| N-PX | 2026-08-11 | xslN-PX_X01/primary_doc.xml | View |
| 4 | 2026-08-07 | FORM 4 | View |
| 4 | 2026-08-07 | FORM 4 | View |
| 144 | 2026-08-06 | xsl144X01/primary_doc.xml | View |
| 13F-HR | 2026-08-06 | xslForm13F_X02/primary_doc.xml | View |
Snapshot, as of 2026-10-07. The original source may contain newer filings.